PremiumThe FlyHologic price target lowered to $71 from $90 at Raymond James Hologic’s Mixed Q2 Performance and Revised Earnings Guidance Lead to Hold Rating Hologic Exceeds Revenue Guidance Amid Challenges PremiumPre-EarningsHOLX Earnings Report this Week: Is It a Buy, Ahead of Earnings? Hologic price target lowered to $75 from $83 at Mizuho Hologic price target lowered to $70 from $86 at BofA PremiumThe FlyHologic cut to Hold at Argus amid slower mammography equipment sales Hologic downgraded to Hold from Buy at Argus Hologic obtains CE Mark for Affirm Contrast Biopsy Software 
